Evidence map›Paper›PMID 41706231›Full record

ArticleBreast cancer research and treatment2026

Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.

Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux, Jun Mao, Vesna Bjelic-Radisic, Michelle J Naughton, Georg Pfeiler, Karen Gelmon and 33 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

43 authors.

Eileen ShinnThe University of Texas MD Anderson Cancer Center, Houston, TX, USA. eshinn@mdanderson.org7896.
David ZahriehMayo Clinic, Rochester, MN, USA.
Angela DeMicheleECOG, University of Pennsylvania, Philadelphia, PA, USA.
Nick ZdenkowskiThe University of Newcastle, Callaghan, NSW, Australia.
Julie LemieuxCentre Hospitalier Universitaire de Québec-Université Laval, Quebec, Canada.
Jun MaoMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Vesna Bjelic-RadisicHelios University Clinic Wuppertal, University Witten/Herdecke Germany, Wuppertal, Germany.
Michelle J NaughtonOhio State University/Alliance, Columbus, OH, USA.
Georg PfeilerDepartment of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Karen GelmonUniversity of British Columbia, Vancouver, BC, Canada.
Justin M BalkoVanderbilt University Medical Center, Nashville, TN, USA.
Daniel EgleMedical University of Innsbruck, Innsbruck, Austria.
Gabriele ZoppoliGruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Policlinico San Martino IRCCS, University of Genoa, Genoa, Italy.
Tiffany TrainaMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Miguel Martin JimenezGEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.
Silvia Antolin NovoaA Coruña University Hospital, A Coruna, Spain.
Tufia HaddadMayo Clinic, Rochester, MN, USA.
Arlene ChanBreast Cancer Research Centre, Nedlands, WA, Australia.
Alistair RingThe Royal Marsden Hospital, NHS Foundation Trust, East Sussex, UK.
Antonio WolffJohns Hopkins University/ECOG, Baltimore, MD, USA.
William Fraser SymmansThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jose Ponce LorenzoGEICAM, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.
Dhanusha SabanathanLakeside Specialist Breast Clinic, Nepean Cancer Care Centre, Norwest, NSW, Australia.
Hal J BursteinDana-Farber Cancer Institute, Boston, MA, USA.
Zbigniew Ireneusz NoweckiThe Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.
Gunda Pristauz-TelsniggMedical University of Graz, Graz, Austria.
Adam BrufskyUniversity of Pittsburgh Cancer Institute UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
Meritxell Bellet-EzquerraVall d'Hebron Institute of Oncology, Barcelona, Spain.
Theodoros FoukakisKarolinska Institute and University Hospital, Solna, Sweden.
Yelena NovikNew York University, New York, NY, USA.
Gabor RubovszkyNational Institute of Oncology, Budapest, Hungary.
Christian F SingerDepartment of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Karoline MuehlbacherAustrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.
Otto Metzger FilhoDana-Farber Cancer Institute, Boston, MA, USA.
Theodora GouliotiBreast International Group, Brussels, Belgium.
Ernest LawPfizer, Chicago, IL, USA.
Ann H PartridgeDana-Farber Cancer Institute, Boston, MA, USA.
Lisa A CareyUniversity of North Carolina/Alliance, Chapel Hill, NC, USA.
Alex ZoroufyMayo Clinic, Rochester, MN, USA.
Dominik HlauschekAustrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.
Christian FeslAustrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.
Erica L MayerDana-Farber Cancer Institute, Boston, MA, USA.
Michael GnantAustrian Breast and Colorectal Cancer Study Group AT, Vienna, Austria.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41706231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.